Compare CVS Health Corp (CVS) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs iShares 10 20 Year Treasury Bond ETF — how do they compare? CVS Health Corp trades at $86.82 (market cap $112.49B), while iShares 10 20 Year Treasury Bond ETF trades at $92.19 (market cap $10.78B). The key difference: CVS Health Corp is far larger — about 10.4× iShares 10 20 Year Treasury Bond ETF's market cap, and CVS Health Corp pays a 3.02% dividend while iShares 10 20 Year Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and iShares 10 20 Year Treasury Bond ETF for 62 Days on average.
| CVS | TLH | |
|---|---|---|
Market Cap | $112.49B | $10.78B |
Volume | 8,467,392 | 4,408,295 |
Sector | Health | Fixed Income |
52-Week High | $110.60 | $105.36 |
52-Week Low | $70.08 | $91.34 |
Typical Hold Time | 83 Days | 62 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
TLH (iShares 10-20 Year Treasury Bond ETF) is trading at $91.45, down 0.12% with a bearish technical signal. The ETF shows unusually high trading volume and faces pressure from rising Treasury yields, which reached multi-decade highs recently. Dividend distributions continue with recent payments of $0.36-$0.38 per share, but key valuation ratios remain unavailable for analysis.
The outlook remains challenging as bond markets face persistent yield pressures from inflation concerns and Fed policy uncertainty. Investment opportunity exists for yield-seeking investors, but risks include continued bond market volatility and potential further yield increases that could pressure ETF prices lower.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
